TC BIOPHARM HOLDINGS PLC TCBWF
*W EXP 02/10/202 · Equity WRT · CUSIP 87807D111
8
institutional holders
+0 vs Q1 2022
6.5m
shares reported held*
$1.3mreported value*
0 new
1 added
1 reduced
0 sold out
net bought ≈ $911 (+4.5k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.21.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2022 | 8 |
| Q2 2022 | 8 |
Biggest buyers
| Virtu Financial LLC | Added | +6.1k |
Biggest sellers
| Warberg Asset Management LLC | Reduced | -1.6k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Empery Asset Management, LP 3.09% of their portfolio | 2.8m $571.0k | Unchanged |
| ARMISTICE CAPITAL, LLC 0.01% of their portfolio | 1.9m $381.0k | Unchanged |
| Altium Capital Management LLC 0.09% of their portfolio | 941.2k $223.0k | Unchanged |
| Kepos Capital LP 0.01% of their portfolio | 470.6k $95.0k | Unchanged |
| Nantahala Capital Management, LLC 0.00% of their portfolio | 235.3k $56.0k | Unchanged |
| Warberg Asset Management LLC 0.01% of their portfolio | 86.7k $18.0k | Reduced -1.6k |
| Virtu Financial LLC 0.00% of their portfolio | 21.9k $4.0k | Added +6.1k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |